NCT03707873: AF-EduCare

Effect of Targeted Education for Atrial Fibrillation Patients

Completed NA Last updated 9 November 2022

What this trial tests

NA trial testing Education in Atrial Fibrillation and Flutter in 1,040 participants. Completed in 30 September 2022.

Timeline

18 October 2018

Primary endpoint
30 September 2022

30 September 2022

Quick facts

Lead sponsor	Universiteit Antwerpen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,040
Start date	18 October 2018
Primary completion	30 September 2022
Estimated completion	30 September 2022
Sites	3 locations across Belgium

Drugs / interventions tested

• Education

Conditions studied

• Atrial Fibrillation and Flutter — all drugs for Atrial Fibrillation and Flutter →

Sponsor

Universiteit Antwerpen — full company profile →

Who can join

18 and older, any sex, with Atrial Fibrillation and Flutter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of targeted in-person and online education on cardiovascular outcomes of AF patients (inpatient and outpatient), compared with standard care. Several other parameters (i.e. knowledge level, quality of life, symptom burden, self-care capabilities, adherence to oral anticoagulation, and an evaluation of the educational efforts) will be studied. Cost-effectiveness and cost-utility will also be investigated.

The main research hypothesis is that individualized education based on the knowledge gaps measured with the JAKQ (Jessa Atrial fibrillation Knowledge Questionnaire) in each individual patient (called 'targeted education') is superior when compared to current AF care, both from an efficacy perspective (evaluated by different outcome measures) and from a cost-effectiveness perspective.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

1. Adherence to oral anticoagulation measured by electronic monitoring in a Belgian atrial fibrillation population.
   Knaepen L, Delesie M, Vijgen J, Dendale P, et al · · 2023 · cited 11× · PMID 37498363 · DOI 10.1007/s00392-023-02261-w
2. Effect of targeted education of patients with atrial fibrillation on unplanned cardiovascular outcomes: results of the multicentre randomized AF-EduCare trial.
   Desteghe L, Delesie M, Knaepen L, Önder R, et al · · 2024 · cited 8× · PMID 39832209 · DOI 10.1093/europace/euae211
3. Engagement of atrial fibrillation patients with the AF-EduApp, a new mobile application to support AF management.
   Knaepen L, Delesie M, Theunis R, Gorissen P, et al · · 2023 · cited 3× · PMID 37823178 · DOI 10.3389/fcvm.2023.1243783
4. Baseline demographics of a contemporary Belgian atrial fibrillation cohort included in a large randomised clinical trial on targeted education and integrated care (AF-EduCare/AF-EduApp study).
   Delesie M, Knaepen L, Dendale P, Vijgen J, et al · · 2023 · cited 3× · PMID 37332586 · DOI 10.3389/fcvm.2023.1186453